128 filings
10-Q
2024 Q1
NKGN
NKGen Biotech Inc
Quarterly report
20 May 24
4:55pm
PRE 14A
NKGN
NKGen Biotech Inc
Preliminary proxy
17 May 24
5:01pm
NT 10-Q
NKGN
NKGen Biotech Inc
15 May 24
Notice of late quarterly filing
4:05pm
S-1/A
NKGN
NKGen Biotech Inc
IPO registration (amended)
13 May 24
4:54pm
8-K
NKGN
NKGen Biotech Inc
13 May 24
Entry into a Material Definitive Agreement
8:05am
8-K
eab2qk42gfn4f0088uc
10 May 24
Entry into a Material Definitive Agreement
4:01pm
8-K
pry2lh3kpxezh
29 Apr 24
Entry into a Material Definitive Agreement
4:01pm
8-K
gn5k2k33clnib 5jd
24 Apr 24
Entry into a Material Definitive Agreement
7:51pm
8-K
7pwp4fw yu9eizvly6t4
11 Apr 24
NKGen Biotech Secures Additional Financing of $5 Million to Continue Advancing Its Clinical Programs
8:05am
8-K
oci301u
5 Apr 24
Entry into a Material Definitive Agreement
4:01pm
NT 10-K
0ciwki v1
1 Apr 24
Notice of late annual filing
4:01pm
8-K
tn4lmm
27 Mar 24
Entry into a Material Definitive Agreement
4:55pm
8-K
xjs b50s3igfo7phqg3
20 Mar 24
Other Events
4:01pm
8-K
sghje2kz8dgs8xvm
15 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
x6zxhdgy1ckg52c4ma
22 Feb 24
Entry into a Material Definitive Agreement
4:01pm
8-K
k5ubwt7 w68y3x
16 Feb 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6:00pm
8-K
3wj1we779 r8gx56
12 Feb 24
Entry into a Material Definitive Agreement
9:25am
8-K
ozajv5 zr83z
8 Feb 24
Departure of Directors or Certain Officers
5:07pm